Navigation Links
R. Kerry Clark and Robert J. Palmisano Join Bausch & Lomb Board of Directors
Date:9/23/2009

ROCHESTER, N.Y., Sept. 23 /PRNewswire/ -- Bausch & Lomb, the global eye health company, today announced R. Kerry Clark and Robert J. Palmisano have joined its board of directors.

"We are adding two outstanding business leaders with broad and relevant experience," said Gerald M. Ostrov, chairman and chief executive officer, Bausch & Lomb. "Choices like these help us become better positioned for long-term growth. We welcome Kerry and Bob and look forward to benefiting from their unique backgrounds and expertise."

Mr. Clark retired in September 2009 as chairman and chief executive officer of Cardinal Health, Inc. (NYSE: CAH), a Fortune 20 company. Under his leadership, Cardinal Health acquired numerous medical technologies that helped the company expand its service to hospitals, pharmacies and clinicians across the United States. Before his leadership at Cardinal Health, Mr. Clark spent more than 30 years at Procter & Gamble Co., where he last served as vice chairman of the board. Mr. Clark is currently a director of Textron, General Mills and Hauser Capital Partners. He holds a bachelor's degree from Queens University.

Mr. Palmisano is the president, chief executive officer and director of ev3 Inc. (Nasdaq: EVVV), a leading global provider of technology for treating peripheral vascular disease and neurovascular diseases. Prior to ev3, Mr. Palmisano was president and chief executive officer for IntraLase Corp., which designed and developed laser products for vision correction, until IntraLase was acquired by Advanced Medical Optics, Inc. He also served as president and chief executive officer for pharmaceuticals firm MacroChem Corporation and Summit Autonomous, Inc., a global medical products company later acquired by Alcon, Inc. Mr. Palmisano has a long history with Bausch & Lomb, holding various executive positions within the company from 1985 to 1996. His last role with Bausch & Lomb was as senior vice president and president of its eyewear division. He holds a bachelor's degree from Providence College.

Mr. Clark and Mr. Palmisano join board members Joseph P. Landy, Elizabeth H. Weatherman and Sean D. Carney, all managing directors of Warburg Pincus LLC; D. Scott Mackesy, general partner, Welsh Carson Anderson & Stowe; Richard Wallman, retired chief financial officer, Honeywell International, Inc.; and Gerald M. Ostrov.

About Bausch & Lomb

Bausch & Lomb is dedicated to bringing visionary ideas to eye health. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. The Bausch & Lomb name is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.


'/>"/>
SOURCE Bausch & Lomb
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years
2. Kerry Extends, Improves Small Business Innovation Program
3. Kerry, Snowe Push Finance Committee on Small Business Health Care
4. Sens. Kerry, Boxer and Feinstein call on FDA to Establish Maximum Level for Lead in Lipstick
5. National Press Club to Host NEWSMAKER Media Briefing on Improving the Cost of Healthcare with R. Kerry Clark
6. Kerry Teel Named President of Premier Anesthesia
7. Senate Passes Senator Kennedys Historic Bill to Regulate Tobacco Products; Senator Kerry Votes to Protect Americas Kids From Tobacco
8. Bob Woodruff, SGM (ret) Colin Rich and Senator John Kerry honored at IBMISPS Annual Awards
9. Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council
10. General Wesley K. Clark (Ret.) to Address Home Care Professionals
11. Barta joins Conseco as Senior Vice President, Financial Planning & Analysis; Barra named Senior Vice President, Internal Audit; Clarke to head Investor Relations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical ... to physician colleagues, skilled nursing facility medical directors and other clinicians at various ... Wound Care." , "At many of these conferences we get to educate other ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: